These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35043668)

  • 1. Utility of Quantitative Metrics From Dual-Layer Spectral-Detector CT for Differentiation of Pancreatic Neuroendocrine Tumor and Neuroendocrine Carcinoma.
    Wang Y; Hu X; Shi S; Song C; Wang L; Yuan J; Lin Z; Cai H; Feng ST; Luo Y
    AJR Am J Roentgenol; 2022 Jun; 218(6):999-1009. PubMed ID: 35043668
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
    Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
    Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological imaging and CT histogram analysis to differentiate pancreatic neuroendocrine tumor grade 3 from neuroendocrine carcinoma.
    Azoulay A; Cros J; Vullierme MP; de Mestier L; Couvelard A; Hentic O; Ruszniewski P; Sauvanet A; Vilgrain V; Ronot M
    Diagn Interv Imaging; 2020 Dec; 101(12):821-830. PubMed ID: 32709455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary differentiation of benign and malignant gastric wall thickening using dual-layer spectral-detector CT.
    Li H; Zhu Q; Liu L; Zou H; Gu D; Wu C; Li W
    Acta Radiol; 2024 Aug; 65(8):879-888. PubMed ID: 39051549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of dual-layer spectral detector computed tomography in the diagnosis of pancreatic neuroendocrine neoplasms.
    Yuan J; Wang Y; Hu X; Shi S; Zhang N; Wang L; Deng W; Feng ST; Peng Z; Luo Y
    Eur J Radiol; 2023 Feb; 159():110660. PubMed ID: 36577182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Energy-Derived Metrics for Differentiating Adrenal Adenomas From Nonadenomas on Single-Phase Contrast-Enhanced CT.
    Loonis AT; Yu H; Glazer DI; Bay CP; Sodickson AD
    AJR Am J Roentgenol; 2023 May; 220(5):693-704. PubMed ID: 36416399
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-layer spectral detector CT: A noninvasive preoperative tool for predicting histopathological differentiation in pancreatic ductal adenocarcinoma.
    Liu W; Xie T; Chen L; Tang W; Zhang Z; Wang Y; Deng W; Xie X; Zhou Z
    Eur J Radiol; 2024 Apr; 173():111327. PubMed ID: 38330535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Utility of Parameters Derived From Pretreatment Dual-Layer Spectral-Detector CT in Patients With Metastatic Renal Cell Carcinoma.
    Drljevic-Nielsen A; Donskov F; Mains JR; Andersen MB; Thorup K; Thygesen J; Rasmussen F
    AJR Am J Roentgenol; 2022 May; 218(5):867-876. PubMed ID: 34910540
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
    Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
    Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
    Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
    Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative parameters of dual-layer spectral detector computed tomography for evaluating differentiation grade and lymphovascular and perineural invasion in colorectal adenocarcinoma.
    Chen J; Ni L; Gong J; Wu J; Qian T; Wang M; Huang J; Liu K
    Eur J Radiol; 2024 Sep; 178():111594. PubMed ID: 38986232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Quantitative Dual-Energy Computed Tomography Parameters for Differentiation of Parotid Gland Tumors.
    Wang Y; Hu H; Ban X; Jiang Y; Su Y; Yang L; Shi G; Yang L; Han R; Duan X
    Acad Radiol; 2024 May; 31(5):2027-2038. PubMed ID: 37730491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of histologic grade of hepatocellular carcinoma using dual-layer spectral-detector computed tomography (CT): comparison of two region of interest plotting methods.
    Zhang K; Zhang J; Li M; Liu X; Xu Y
    Quant Imaging Med Surg; 2024 Jun; 14(6):3887-3900. PubMed ID: 38846284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
    Li JK; Wang M; Yuan J; Song ZG
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
    [No Abstract]   [Full Text] [Related]  

  • 17. Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features.
    van der Pol CB; Lee S; Tsai S; Larocque N; Alayed A; Williams P; Schieda N
    Abdom Radiol (NY); 2019 Mar; 44(3):992-999. PubMed ID: 30603880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical feasibility of using effective atomic number maps derived from non-contrast spectral computed tomography to identify non-calcified atherosclerotic plaques: a preliminary study.
    Chen W; Li R; Yin K; Liang J; Li H; Chen X; Sheng Z; Yu H; Mu D
    Quant Imaging Med Surg; 2022 Apr; 12(4):2280-2287. PubMed ID: 35371951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nomogram based on dual-layer detector spectral computed tomography quantitative parameters and morphological quantitative indicator for distinguishing metastatic and nonmetastatic regional lymph nodes in pancreatic ductal adenocarcinoma.
    Wen Y; Song Z; Li Q; Zhang D; Li X; Liu Q; Yu J; Li Z; Ren X; Zhang J; Zeng D; Tang Z
    Quant Imaging Med Surg; 2024 Jul; 14(7):4376-4387. PubMed ID: 39022223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features?
    Gulpinar B; Peker E; Kul M; Elhan AH; Haliloglu N
    Abdom Radiol (NY); 2019 Jun; 44(6):2147-2155. PubMed ID: 30863999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.